Editorial Board About Us

Gene therapy

All articles from this key word are listed below.

Volume 2, Number 3 Meeting Reviews

Focus on Sexual Dysfunction, Tissue Engineering, Gene Therapy

First Fall Meeting, Society for the Study of Impotence

Tissue engineering Gene therapy Sexual dysfunction Prostheses, penile

Volume 3, Number 4 Review Articles

Prostate Cancer Gene Therapy--What Have We Learned and Where Are We Going?

Treatment Update

Yasutomo Nasu Bob Djavan

Prostate cancer Gene therapy Immunomodulatory genes Suicide genes Viral vectors Oncogenes

Volume 3, Number 3 Meeting Reviews

Interstitial Cystitis and Bladder Research: Progress and Future Directions

NIDDK and ICA International Research Symposium

Naoki Yoshimura Michael B Chancellor

Gene therapy Antiproliferative factor (APF)Epidermal growth factor (EGF)Heparin-binding epidermal growth factor-like growth factor (HB-EGF)Herpes simplex virus Interstitial cystitis (IC)IC, in men IC, in children Intravesical peppers Substance P (SP)

Volume 3, Supplement 1 Supplement

Future Trends in the Treatment of Urinary Incontinence

Michael B Chancellor

Urinary incontinence Capsaicin Gene therapy Afferent blockade Anticholinergic Chili pepper Neurokinin · Overactive bladder Resiniferitoxin

Volume 4, Supplement 3 Supplement

Future Strategies for Treating Erectile Dysfunction

Thomas Magee Nestor Gonzalez-Cavidad Jacob Rajfer

Erectile dysfunction Sildenafil Gene therapy Nitric Oxide Smooth muscle cells Cyclic guanosine monophosphate

Volume 7, Number 4 Review Articles

Adenoviral Gene Therapy, Radiation, and Prostate Cancer

Therapeutic Challenges

Ronald Rodriguez Shawn E Lupold

Prostate cancer Gene therapy Radiation therapy Adenovirus Suicidegene therapy Oncolytic virus Conditionally replicating adenovirus (CRAD)

Volume 7, Number 3 Review Articles

The Molecular Basis of Erectile Dysfunction: From Bench to Bedside

Treatment Update

Sweaty Koul Hari Koul Albaha Barqawi Randall B Meacham Jesse N Mills

Erectile dysfunction Gene therapy Molecular Apoptosis Nitric Oxide

Volume 7, Supplement 2 Review Articles

Neuroregenerative Strategies After Radical Prostatectomy

Tom F Lue Robert C Dean

Radical prostatectomy Erectile dysfunction Gene therapy Impotence

Volume 9, Supplement 1 Review Articles

Clinical Experience With Gene Therapy for the Treatment of Prostate Cancer

New Directions in the Management of Advanced Prostate Cancer

Matthew A Stanizzi Simon J Hall

Localized prostate cancer can be treated effectively with radical prostatectomy or radiation therapy. The treatment options for metastatic prostate cancer are limited to hormonal therapy; hormone-refractory cancer is treated with taxane-based chemotherapy, which provides only a modest survival benefit. New treatments are needed. The gene for the initiation of prostate cancer has not been identified; however, gene therapy can involve tumor injection of a gene to kill cells, systemic gene delivery to target and kill metastases, or local gene expression intended to generate a systemic response. This review will provide an overview of the various strategies of cancer gene therapy, focusing on those that have gone to clinical trial, detailing clinical experience in prostate cancer patients. [Rev Urol. 2007;9(suppl 1):S20-S28]

Prostate cancer Prostate-specific antigen Gene therapy